Patents by Inventor Suzhen CHEN

Suzhen CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12091378
    Abstract: The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: September 17, 2024
    Assignees: GLOBE BIOMEDICAL CO., LTD., GLOBE HEALTH INSTITUTE LLC
    Inventors: Chiang J. Li, Suzhen Chen, Jifeng Liu
  • Publication number: 20230080823
    Abstract: A Device and method for third low-temperature controllable nuclear fusion is disclosed. The main substances used for nuclear fusion in the disclosure are polyatomic molecules, namely lithium deuteride 6, lithium deuteride 7 and beryllium 9, and a specific method for controlling the intensity of nuclear fusion reaction is provided. After neutrons are generated, a neutron proliferation reaction and a self-circulation continuous nuclear fusion reaction are formed. The main reaction is as follows: firstly, deuterons react with one another to generate neutrons, then the neutrons react with a lithium-6 nucleus d to generate a tritium nucleus t, the t reacts with a lithium-7 nucleus, the neutrons react with a beryllium-9 nucleus, and finally, two neutrons and two helium-4 nucleuses are released.
    Type: Application
    Filed: July 7, 2022
    Publication date: March 16, 2023
    Inventor: SUZHEN CHEN
  • Publication number: 20220281810
    Abstract: The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 8, 2022
    Inventors: Chiang J. LI, Suzhen CHEN, Jifeng LIU
  • Patent number: 11370748
    Abstract: The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: June 28, 2022
    Assignees: 1GLOBE BIOMEDICAL CO., LTD., 1GLOBE HEALTH INSTITUTE LLC
    Inventors: Chiang J. Li, Suzhen Chen, Jifeng Liu
  • Publication number: 20200283378
    Abstract: The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
    Type: Application
    Filed: September 5, 2018
    Publication date: September 10, 2020
    Inventors: Chiang J. LI, Suzhen CHEN, Jifeng LIU